rs775842693
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_021005.4(NR2F2):c.172G>A(p.Gly58Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000514 in 1,555,868 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G58R) has been classified as Uncertain significance.
Frequency
Consequence
NM_021005.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.00000658  AC: 1AN: 151954Hom.:  0  Cov.: 31 show subpopulations 
GnomAD2 exomes  AF:  0.00000639  AC: 1AN: 156396 AF XY:  0.0000118   show subpopulations 
GnomAD4 exome  AF:  0.00000499  AC: 7AN: 1403914Hom.:  0  Cov.: 31 AF XY:  0.00000144  AC XY: 1AN XY: 693404 show subpopulations 
GnomAD4 genome  0.00000658  AC: 1AN: 151954Hom.:  0  Cov.: 31 AF XY:  0.0000135  AC XY: 1AN XY: 74216 show subpopulations 
ClinVar
Not reported inComputational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at